Article
Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.
Stem cells and development - 1 Aug 2010
Houghton JeanMarie, Li Hanchen, Fan Xueli, Liu Yingwang, Liu Jian Hua, Rao Varada P, Poutahidis Theofilos, Taylor Christie L, Jackson Erin A, Hewes Christine, Lyle Stephen, Cerny Anna, Bowen Glennice, Cerny Jan, Moore Nathan, Kurt-Jones Evelyn A, Erdman Susan E
Abstract excerpt
Neoplastic epithelia may remain dormant and clinically unapparent in human patients for decades. Multiple risk factors including mutations in tumor cells or the stromal cells may affect the switch from dormancy to malignancy. Gene mutations, including p53 mutations, within the stroma of tumors ar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
